PubMed |
Abstract |
RScore(About this table) |
18593248 |
Kisseberth WC, Murahari S, London CA, Kulp SK, Chen CS: Evaluation of the effects of histone deacetylase inhibitors on cells from canine cancer cell lines. Am J Vet Res. 2008 Jul;69(7):938-45.
|
2(0,0,0,2) |
Details |
19448855 |
Gavin DP, Rosen C, Chase K, Grayson DR, Tun N, Sharma RP: Dimethylated lysine 9 of histone 3 is elevated in schizophrenia and exhibits a divergent response to histone deacetylase inhibitors in lymphocyte cultures. J Psychiatry Neurosci. 2009 May;34(3):232-7.
|
2(0,0,0,2) |
Details |
20118114 |
Lu Y, Nie J, Liu X, Zheng Y, Guo SW: Trichostatin A, a histone deacetylase inhibitor, reduces lesion growth and hyperalgesia in experimentally induced endometriosis in mice. Hum Reprod. 2010 Apr;25(4):1014-25. Epub 2010 Jan 29.
|
2(0,0,0,2) |
Details |
19584707 |
Rahim R, Strobl JS: Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells. Anticancer Drugs. 2009 Sep;20(8):736-45.
As an earlier study suggested that CQ, HCQ, and ATRA are breast cancer cell differentiation agents, these agents were screened in cell-free histone deacetylase (HDAC) and histone acetyltransferase (HAT) assays. |
1(0,0,0,1) |
Details |
19295477 |
Li Y, Liu B, Zhao H, Sailhamer EA, Fukudome EY, Zhang X, Kheirbek T, Finkelstein RA, Velmahos GC, deMoya M, Hales CA, Alam HB: Protective effect of suberoylanilide hydroxamic acid against LPS-induced septic shock in rodents. Shock. 2009 Nov;32(5):517-23.
We have recently found that suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, improves survival in a lethal model of hemorrhagic shock in rats. |
1(0,0,0,1) |
Details |